Why insider trading matters?
If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.
Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Moderna, Inc. also has a collaboration with Lonza Ltd. for the manufacture of mRNA-1273, a COVID-19 vaccine. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
| Trade Date | Insider | Title | Buy/Sell | #Shares | Price | Value | Option |
|---|---|---|---|---|---|---|---|
| 2022-02-24 | Bancel Stephane | Chief Executive Officer | Sell | 19,000 | $142.07 | $2,699,400 | No |
| 2022-02-24 | Andres Juan | nan | Sell | 2,000 | $150.00 | $300,000 | Yes |
| 2022-02-16 | Andres Juan | nan | Sell | 2,000 | $150.00 | $300,000 | Yes |
| 2022-02-17 | Bancel Stephane | Chief Executive Officer | Sell | 19,000 | $149.22 | $2,835,100 | No |
| 2022-02-14 | Hoge Stephen | President | Sell | 20,000 | $157.71 | $3,154,200 | Yes |
| 2022-02-10 | Andres Juan | nan | Sell | 2,768 | $155.55 | $430,549 | Yes |
| 2022-02-10 | Meline David W | Chief Financial Officer | Sell | 619 | $158.89 | $98,354 | Yes |
| 2022-02-10 | Bancel Stephane | Chief Executive Officer | Sell | 19,000 | $156.25 | $2,968,840 | No |
| 2022-02-02 | Andres Juan | nan | Sell | 2,000 | $170.89 | $341,780 | Yes |
| 2022-02-03 | Hoge Stephen | President | Sell | 20,000 | $167.94 | $3,358,900 | Yes |
| 2022-02-03 | Bancel Stephane | Chief Executive Officer | Sell | 19,000 | $167.79 | $3,188,010 | No |
| 2022-01-27 | Bancel Stephane | Chief Executive Officer | Sell | 19,000 | $157.65 | $2,995,400 | No |
| 2022-01-24 | Hoge Stephen | President | Sell | 20,000 | $150.67 | $3,013,451 | Yes |
| 2022-01-20 | Bancel Stephane | Chief Executive Officer | Sell | 19,000 | $181.42 | $3,447,050 | No |
| 2022-01-13 | Bancel Stephane | Chief Executive Officer | Sell | 19,000 | $219.77 | $4,175,690 | No |
| 2022-01-13 | Hoge Stephen | President | Sell | 20,000 | $219.67 | $4,393,450 | Yes |
| 2022-01-06 | Bancel Stephane | Chief Executive Officer | Sell | 19,000 | $223.27 | $4,242,200 | No |
| 2021-12-31 | Andres Juan | nan | Sell | 5,000 | $249.88 | $1,249,400 | Yes |
| 2022-01-03 | Hoge Stephen | President | Sell | 20,000 | $247.08 | $4,941,600 | Yes |
| 2021-12-30 | Bancel Stephane | Chief Executive Officer | Sell | 10,000 | $243.42 | $2,434,200 | No |
| 2021-12-29 | Andres Juan | nan | Sell | 5,000 | $240.00 | $1,200,000 | Yes |
| 2021-12-29 | Bancel Stephane | Chief Executive Officer | Sell | 9,000 | $240.00 | $2,160,000 | No |
| 2021-12-27 | Andres Juan | nan | Sell | 10,000 | $243.10 | $2,431,000 | Yes |
| 2021-12-23 | Hoge Stephen | President | Sell | 15,000 | $247.30 | $3,709,548 | Yes |
| 2021-12-23 | Bancel Stephane | Chief Executive Officer | Sell | 10,000 | $250.41 | $2,504,100 | No |
| 2021-12-22 | Andres Juan | nan | Sell | 5,000 | $264.26 | $1,321,300 | Yes |
| 2021-12-22 | Bancel Stephane | Chief Executive Officer | Sell | 9,000 | $264.26 | $2,378,340 | No |
| 2021-12-15 | Andres Juan | nan | Sell | 5,000 | $272.11 | $1,360,550 | Yes |
| 2021-12-16 | Bancel Stephane | Chief Executive Officer | Sell | 19,000 | $278.47 | $5,290,990 | No |
| 2021-12-13 | Hoge Stephen | President | Sell | 20,000 | $257.01 | $5,140,200 | Yes |
Insider Smart
Insider Smart